The Canada-Israel Cardiovascular Innovation Forum held an innovation competition targeting early and mid-stage companies with projects in either cardiovascular devices or digital heart health. A total of 31 applications were received and 9 were selected to present their innovation at the April 25th CICI Forum Virtual Event. See the list of presenters and applicants below or you may download the list of presenting companies (with summaries of the innovations) or a non-exhaustive list of other innovations submitted to the competition (summaries included).


​Applicant: Stephanie Buryk-Iggers

Company: SPARKED

Innovation: Handheld, non-invasive device for early risk detection of cardiovascular disease
(read summary of innovation)
(view video of presentation)

​Applicant: Daniel Gelman

Company: Aufero Medical

Innovation: Device to stabilize contact force during radiofrequency catheter ablation therapy for atrial fibrillation (view summary of innovation

​Applicant: Surath Gomis

Company: Arma Biosciences

Innovation: A handheld device for rapid, continuous remote monitoring of biochemical markers in patients with heart failure (read summary of innovation)

(view video of presentation)

Applicant: Ali Tavallaei

Company: Magellan Biomedical Inc.

Innovation: A novel catheter allowing for accurate localized steering and tracking of endoluminal devices
(view summary of innovation

Applicant: Ryan Tennant

Company: No named company

Innovation: A novel re-entry device for angioplasty of coronary and peripheral chronic total occlusions
(read summary of innovation

(view video of presentation)



​Applicant: Lihu Avitov

Company: Revamp Medical

Innovation: The Doraya Catheter - a novel temporary intravenous flow regulator
(read summary of innovation

(view video of presentation)

​Applicant: Nitai Hanani

Company: Paragate Medical Ltd.

Innovation: Implantable Peritoneal Ultrafiltration Device (IPUD) for continuous and active fluid decongestion in heart failure patients
(view summary of innovation

​Applicant: Elon Reshef

Company: Invatin Technologies Ltd.

Innovation: A novel continuous stroke prevention device
(read summary of innovation)

(view video of presentation)

Applicant: Ariel Weigler

Company: Cuspa Ltd.

Innovation: Transcatheter artificial cusp for repair of valve insufficiency
(read summary of innovation

(view video of presentation)


​Applicant: Sachin Davis

Company: Flora Bioworks

Innovation: A non-invasive diagnostic platform for the identification of atherosclerotic cardiovascular disease via metagenomic sequencing of the gut microbiome
(view summary of innovation

​Applicant: Marko Jovic

Company: Cardian Diagnostics

Innovation: Saliva-based non-invasive monitoring for heart failure patients (view summary of innovation

​Applicant: Haman Mamdouhi

Company: Health-Bridge

Innovation: Health-Bridge: eliminating the language barrier in health care (view summary of innovation)



​​Applicant: Doron Adler

Company: Sanolla

Innovation: AI Powered Primary Care Diagnostics Solutions
(view summary of innovation

​Applicant: Arie Huber

Company: PRC Cardio Optic Ltd.

Innovation: An innovative Imaging System For Directing Guidewire Crossing in Arterial Chronic Total Occlusion (“CTO”) and Reducing Contrast Reagent Use in Coronary Angiography (view summary of innovation)

Applicant: Jonathan Maron

Company: VenoVision

Innovation: VenoVision Hemodynamic Remote Monitoring Platform (view summary of innovation


Early-stage companies, seeking <$500k with projects in either cardiovascular devices or digital health are invited to submit applications.  Judging panels from Canada and Israel will assess the projects of the other country. The top-rated projects from Israel and Canada in each category will present for 15 minutes with 5-minute question session on May 15, 2022. Investors interested in cardiovascular innovations in both countries will be invited to attend the presentations virtually and to contact the companies of interest after the presentation. There will be no application charges or attendance fees. 

Canada-Israel Cardiovascular Innovation Forum does not commit funding to any applying group presenting at the forum, is not responsible for the statements of any group, and does not bear any legal or financial responsibility for arrangements between investors and presenters that result from the Forum.